AzTrials
AzTrials

Vaginal Vault ProlapseNCT05960292

Laparoscopic Versus Vaginal Approach Closure Complications

A study testing Laparoscopic and Vaginal Hysterectomy in people with Vaginal Vault Prolapse, run by Egymedicalpedia at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Hysterectomy is considered as a common operation in Gynecology. Hysterectomy could be made by vaginally, laparoscopically or abdominally. The American Congress of Obstetricians and Gynecologist advises the use of a minimally invasive technique for the sake of women and to decrease hospital stay and costs. Read more about this study

Who is it for?
Ages 40 to 80 years, women only
Conditions the study is for
Vaginal Vault Prolapse
What is being tested?
Laparoscopic and Vaginal Hysterectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteEgypt
Study dates
1 Aug 2023to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who undergo laparoscopic hysterectomy
  • Age ranged from 40 to 80 years.
  • Patients suffering from chronic pelvic inflammatory disease (PID)
  • Dysfunctional uterine bleeding
  • Adenomyosis
  • Endometriosis
Show all 9Show fewer
  • Fibroid
  • Endometrial hyperplasia
  • Benign ovarian cyst

Who cannot join

  • Patients with known malignancy

Trial locations and contacts

1 site in 1 country.

Mohamed Adel, MSC contact

+201065702255

elhoseeeeeeny@gmail.com

Egypt1 site, 1 recruiting
  • Al-Azhar University hospitals

    Cairo, 13111

    ElSayed ElDesouky, Assist.Prof, 01092934978, elsayedeldesouky@yahoo.com

    Ahmed Altaf, Professor

    Recruiting

Other trials in Egypt

About this study

Official title: Laparoscopic Versus Vaginal Approach Closure Complications of Vaginal Vault in Laparoscopic Hysterectomy

Hysterectomy is considered as a common operation in Gynecology. Hysterectomy could be made by vaginally, laparoscopically or abdominally. The American Congress of Obstetricians and Gynecologist advises the use of a minimally invasive technique for the sake of women and to decrease hospital stay and costs.

Read the detailed description

Laparoscopic hysterectomy (LH) is a minimally invasive operation that could be made when vaginal hysterectomy is not accessible due to anatomical problems.

Vaginal cuff dehiscence (VCD) is a severe adverse event and occurs more frequently after total laparoscopic hysterectomy (TLH) compared with abdominal and vaginal hysterectomy.

The study shows effects of the laparoscopic approach versus the vaginal route for the management of vaginal cuff closure during total laparoscopic hysterectomy on female sexual function.

Being tested
Laparoscopic and Vaginal Hysterectomy
Keywords
Laparoscopic hysterectomy, Vaginal hysterectomy
Medical subject headings
Pelvic Organ Prolapse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic and Vaginal HysterectomyProcedure or surgery

    To make a comparison between the Vaginal Vault complications after Hysterectomy

Study groups in NCT05960292
Study groupRoleWhat they receive
Vaginal Hysterectomy (Group)Active comparatorAbout 28 female patients will have vaginal vault closure by vaginal approach
Receives: Procedure: Laparoscopic and Vaginal Hysterectomy
Abdominal Laparoscopic Hysterectomy (Group)Active comparatorAbout 28 female patients will have vaginal vault closure by Abdominal Laparoscopic approach
Receives: Procedure: Laparoscopic and Vaginal Hysterectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post operative bleeding (defined as blood loss ≥500 cc)

    Amount of lost blood will be measured in terms of assessment of Hemoglobin and Hematocrit levels before and after operation.

    Measured: First 24 hours after The Operations

  2. Postoperative pain

    Assessment of the pain post-operatively in patients with pain score as : Total scores vary from 0 to 10 in this method, with a higher score indicating more severe pain

    Measured: First 24 hours after The Operations

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2023
  2. Study start1 Aug 2023
  3. Primary completion1 Apr 2024 (estimated)
  4. Study completion30 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
56 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05960292
Sponsor's protocol ID
Mohamed Adel Hussien
Status last verified
Sep 2023
First submitted
12 Jul 2023
Last updated
7 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Laparoscopic and Vaginal Hysterectomy in people with Vaginal Vault Prolapse, run by Egymedicalpedia at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Adel, MSC (+201065702255, elhoseeeeeeny@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post operative bleeding (defined as blood loss ≥500 cc) (time frame: First 24 hours after The Operations). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in